DOMPE FARMACEUTICI SPA
Desconocido
REMEDI4ALL: BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL
DOMPE FARMACEUTICI SPA
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2021-DISEASE-04
REMEDI4ALL aims to establish Europe's leadership globally in the repurposing of medicines by creating a vibrant community of practice coveri...
2022-05-19 - 2027-08-31 | Financiado
2022-05-19 - 2027-08-31 | Financiado
TwistedNano: Twisted nanophotonic technology for integrated chiroptical sensing of drugs on a chip
DOMPE FARMACEUTICI SPA
participó en un
HORIZON EUROPE:
HORIZON-EIC-2021-PATHFINDEROPEN-01
The quest for new medical drugs demands reliable, ultrasensitive and fast techniques to identify, refine and test small volumes of candidate...
2022-02-07 - 2026-07-31 | Financiado
2022-02-07 - 2026-07-31 | Financiado
LIGATE: LIgand Generator and portable drug discovery platform AT Exascale
DOMPE FARMACEUTICI SPA
tramitó un
H2020:
H2020-JTI-EuroHPC-2019-1
Today digital revolution is having a dramatic impact on the pharmaceutical industry and the entire healthcare system.
The implementation of...
2020-12-16 - 2024-04-30 | Financiado
2020-12-16 - 2024-04-30 | Financiado
EUROCC: National Competence Centres in the framework of EuroHPC
DOMPE FARMACEUTICI SPA
participó en un
H2020:
H2020-JTI-EuroHPC-2019-2
The EuroCC activity will bring together the necessary expertise to set up a network of National Competence Centres in HPC across Europe in 3...
2020-08-31 - 2022-12-31 | Financiado
2020-08-31 - 2022-12-31 | Financiado
EXSCALATE4CoV: EXaSCale smArt pLatform Against paThogEns for Corona Virus
DOMPE FARMACEUTICI SPA
tramitó un
H2020:
H2020-SC1-PHE-CORONAVIRUS-2020
The EXSCALATE4CoV (E4C) project aims to exploit the most powerful computing resources currently based in Europe to empower smart in-silico d...
2020-04-08 - 2021-09-30 | Financiado
2020-04-08 - 2021-09-30 | Financiado
ANTAREX: AutoTuning and Adaptivity appRoach for Energy efficient eXascale HPC systems
DOMPE FARMACEUTICI SPA
participó en un
H2020:
H2020-FETHPC-2014
Energy-efficient heterogeneous supercomputing architectures need to be coupled with a radically new software stack capable of exploiting the...
2015-06-29 - 2018-11-30 | Financiado
2015-06-29 - 2018-11-30 | Financiado
INCIPIT: INnovative Life sCIence Phd Programme in South ITaly
DOMPE FARMACEUTICI SPA
participó en un
H2020:
H2020-MSCA-COFUND-2014
INCIPIT is a novel international PhD programme, which aims at providing innovative multidisciplinary and intersectoral training in Life and...
2015-05-13 - 2021-12-31 | Financiado
2015-05-13 - 2021-12-31 | Financiado
TIMER: TargetIng novel MEchanisms of Resolution in inflammation
DOMPE FARMACEUTICI SPA
participó en un
FP7:
Resolution of inflammation is a key determinant of pathology, and an active process which involves diverse pathways and molecules. The gener...
Financiado
Financiado
GAPP: GAbapentin in Paediatric Pain
DOMPE FARMACEUTICI SPA
participó en un
FP7:
Chronic pain is estimated to affect 15-20% of children with varying disabilities. Due to the paucity of clinical information and appropriate...
Financiado
Financiado
* No se disponen de datos de la empresa actual.